Quality of life in smokers: Focus on functional limitations rather than on lunq function?

British Journal of General Practice

Volumn 57, Issue 539, 2007, Pages 477-482

  Geijer, Roeland M M ^a   Sachs, Alfred P E ^a   Verheij, Theo J M ^a   Kerstjens, Huib A M ^b   Kuyvenhoven, Marijke M ^a   Hoes, Arno W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Dyspnoea; FEV1; Middle aged; Quality of life; Smokers

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SMOKING; SPIROMETRY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SMOKING; VITAL CAPACITY;

EID: 34250217810     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pauwels RA, Buist S, Calverley PMA, et al, on behalf of the GOLD Scientific Committee Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease; NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). Arm J Respir Crit Care Med 2001; 163(5): 1256-1276.
2. Fabbri LM, Hurd SS, for the GOLD Scientific Committee. Global Strategy for the Diagnosis Management and Prevention of COPD: 2003 update. Eur Resp J 2003; 22: 1-2.
3. Wilson IB, Cleary PD. Linking clinical variables with health related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273(1): 59-65.
4. Wijnhoven HAH, Kriegsman DMW, Hesselink AE, et al. Determinants of different dimensions of disease severity in asthma and COPD; pulmonary function and health related quality of life. Chest 2001; 119: 1034-1042.
5. Antonell-Incalzi R, lmperiale C, Bellia V, et al. Do GOLD stages of COPD severity really correspond to difference in health status? Eur Respir J 2003; 22(3): 444-449.
6. Bestall JC, Garrod PR, Garnham R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
7. Kerstjens HAM. The GOLD classification has not advanced understanding of COPD. Am I Respir Crit Care Med 2004; 170: 212-213.
8. Mahler DA, Mackowiak JI. Evaluation of the Short-Form 36-Item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995; 107 b: 1585--1589.
9. Hajiro T, Nishimura K, Tsukoni M, et al. A comparison of the level of dyspnoea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116: 1632-1637.
10. Geijer RMM, Sachs APE, Hoes AW, et al. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old. Fam Pract 2005; 22(5): 485-489.
11. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152(3): 1107-1136.
12. Quanjer PH, Tammeling GJ, Cotes JE, et al, on behalf of the working party (Standardization of lung function testing). Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J suppl 1993; 6(suppl): 5-40.
13. Thiadens HA. Questionnaire Diagnosing asthma or COPD in patients with persistent cough: variations on a theme. Leiden: University of Leiden, 1999.
14. Fletcher CM (Chairman). Standardized questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ 1960; 2: 1665.
15. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998; 51(11): 1055--1068.
16. Maille AR, Koning CJ, Zwinderman AH, et al. The development of the 'Quality-of-life for Respiratory Illness Questionnaire (QOLRIQ)': a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med 1997; 91(5): 297-309.
17. Van Manen JG, Bindels PJE, Dekker FW, et al. The influence of COPD on health-related quality of life independent of the influence of co-morbidity. J Clin Epidemiol 2003; 56(12): 1177-1184.
18. Curtis, JR, Patrick DL. The assessment of health status among patients with COPD. Eur Resp J 2003; 21 Suppl(41): 36S-45S.
19. Van Stel HF, Maillé R, Colland VT, Everaerd W. Interpretation of change and longitudinal validity of the quality of life for respiratory illness questionnaire (QOLRIQ) in inpatient pulmonary rehabilitation. Qual Life Res 2003; 12(2): 133-145.
20. Hajiro T, Nishimura K, Tsukoni M, et al. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157 (3 Pt 1): 785-790.
21. Geijer RMM, Sachs APE, Verheij TJM, et al. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Br J Gen Pract 2006; 56(530): 656-661.
22. Viramontes JL, O'Brien B. Relationships between symptoms and health-related quality of life in chronic lung diseases. Gen Inter Med 1994; 9(1): 46--48.
23. Maillé AR. Quality of life in asthma and COPD. Development of a disease-specific questionnaire (Thesis). Amsterdam: University of Amsterdam, 2000.
24. Hajiro T, Nitshimura K, Tsukino M, et al. Analysis of clinical methods used to evaluate dyspnoea in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1998; 158(4): 1185-1189.
25. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease and health-related quality of life. Ann Int Med 1987; 127(12): 1072-1079.
26. Engstróm CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J 2001; 18(1): 69-76.
27. Langhammer A, Johnsen R, Gulsvik A, et al. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003; 21(6): 1017-1023.
28. Langhammer A, Johnsen R, Holmen J, et a. Cigarette smoking gives more respiratory symptoms among women than among men. J Epidemiol Comm Health 2000; 54(12): 917-922.
29. Kerstjens HA, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 1997; 52: 820-827.
30. Braspenning JCC, Schellevis, FG, Grol RPTM (eds). Second national survey of diseases in primary care. Utrecht: NIVEL/WOK, 2004.
31. Hajiro T, Nishimura K, Tsukino M, et al. Stages of disease severity and factors that affect the health status of patients with chronic obstructive disease. Resp Medicine 2000; 94(9): 841-846.i
32. Celli BR, Cote CG, Marin JM, et al. The body-mass Index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10): 1005-1012.